Marine Ingredients, a KD Pharma Group company announced today at the VitaFoods Europe Exhibition in Switzerland that it has expanded its organization to support the global omega-3 nutraceutical market. The expanded scope is a structural alignment following its merger with KD Pharma announced last October. This new structure allows Marine Ingredients to provide a complete spectrum of omega-3 concentrates and minimally processed marine oils to the global nutraceutical market. KD Pharma will focus its business efforts on its market leadership in pharmaceutical development, API and the generic API marketplace.
"This alignment helps us provide a consistent brand presence in the two market verticals we serve," said Marine Ingredients President, Olav Sandnes. "Together with KD Pharma’s broad technological capabilities and Marine Ingredients 35 years experience in the nutraceutical market, Marine Ingredients is well positioned to support the growing worldwide omega-3 market and expand its global nutraceutical market share."
The KD Pharma group is the 3rd largest supplier of omega-3 in the world. Together with Marine Ingredients A/S in Norway and the InnovaGel softgel facility in Miami, Marine Ingredients can provide its customers with a full spectrum of omega-3 oil concentrations and ratios of omega-3 as bulk oils, bottled liquids, and finished soft-gels.
"Our merger with Marine Ingredients and the formation of the KD Pharma Group expands our presence in every market worldwide" said Oscar Groet, CEO of the KD Pharma Group. "We have products suitable for emerging markets, health and wellness segments, and the Pharmaceutical markets that are looking for our innovations in omega-3 science to develop new drugs focused on inflammation, cardiovascular health as well as age related cognitive decline."